Trials / Completed
CompletedNCT04221269
Suicide Prevention Intervention for Schizophrenia-Spectrum Disorders
Post-Hospital Suicide Prevention Intervention for Patients With Schizophrenia-Spectrum Disorders
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Butler Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The current project is a pilot randomized controlled trial to test the Coping Long-term with Active Suicide Program for schizophrenia-spectrum disorders (CLASP-S) for patients following a psychiatric hospitalization. Participants will be assigned to enhanced treatment as usual (ETAU) alone vs CLASP-S plus ETAU. Participants complete assessments at baseline during their psychiatric hospitalization and at 3 months (mid-treatment) and 6 months (post-treatment) following discharge. The primary aim is to assess the feasibility and acceptability of CLASP-S. The secondary aim is to estimate the effects of CLASP-S on reducing suicidal thoughts and behaviors relative to ETAU.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Enhanced Treatment as Usual | Routine community care plus assessment feedback reports to clinicians. |
| BEHAVIORAL | Coping Long-term with Active Suicide Program for Schizophrenia | Adjunctive psychosocial intervention for suicide prevention involving in person, family, and phone sessions. |
Timeline
- Start date
- 2020-12-01
- Primary completion
- 2023-06-01
- Completion
- 2023-06-01
- First posted
- 2020-01-09
- Last updated
- 2023-07-11
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04221269. Inclusion in this directory is not an endorsement.